CinRx Pharma, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
CinRx Pharma, LLC - overview
Established
2015
Location
Cincinnati, OH, US
Primary Industry
Biotechnology
About
Founded in 2015 and based in Ohio, US, CinRx Pharma, LLC acts as a consultant to drug candidates at different phases of development and helps develop therapeutics for unmet medical needs. In May 2024, the firm raised USD 73 million in venture funding from returning investors Perceptive Advisors, with participation from Individual investors. The company was founded by Jon Isaacsohn, who is leading the firm as CEO as of 2024. CinRx Pharma’s product offerings include a diverse pipeline of drug candidates targeting a range of conditions, such as metabolic diseases, hypertension, and neurodegenerative disorders.
Notable assets in their pipeline include CIN-110, currently in Phase 1 clinical trials for the treatment of obesity, and other candidates under development in partnership with various biopharmaceutical entities. The company plans to use the May 2024 funding to accelerate its development in existing portfolio programs and expand its reach.
Current Investors
Perceptive Advisors
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.cinrx.com
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.